Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT07311031
Starting soon Not applicable

Effect of Blood Flow Restriction Rraining on Rehabilitation After Anterior Cruciate Ligament Reconstruction

NCT07311031 · tracked via the Priya Life Science Spain tracker
Sponsor
Hospital MAZ
Phase
Not applicable
Started
2025-12-20
Last updated
2026-01-05

Condition(s) studied

Anterior Cruciate Ligament Reconstruction RehabilitationBlood Flow Restriction (BFR) Training Effects

Investigational drug(s) / intervention(s)

Blood flow restriction trainingStandard ACL rehabilitation

Blood flow restriction training: BFRT consists of a pressurized cuff that is applied to the proximal thigh in order to partially occlude blood flow while the patient exercises. It is believed that the accumulated effects of fatigue, mechanical tension, metabolic stress and reactive hyperaemia contribute to promoting adaptation of the quadriceps with minimal strain. Therefore, patients can train at reduced loads and may receive the same training benefits as if they were training with high loads.

Standard ACL rehabilitation: A 14-16-week supervised accelerated early rehabilitation protocol was selected based on previous evidence.8 It is characterised by early unrestricted motion and weight-bearing, without the use of an immobilising brace and commencing early strength training.

Study summary

Importance: Following anterior cruciate ligament reconstruction (ACLR), patients often experience quadriceps muscle weakness and atrophy, frequently leading to long-term complications. A promising rehabilitation program based on blood flow restriction training (BFRT) seems to be particularly valuable for patients who may be unable to train with heavy loads due recent surgery. Previous studies have demonstrated that BFRT promotes strength gains and muscle mass increases, with adaptations comparable to traditional high-intensity training, despite using low-load resistance exercises.

Objective: to evaluate the effect of blood flow restriction training on quadriceps strength and knee biomechanics in a 4-month rehabilitation program of patients who have had an ACL reconstruction.

Design: The study will be a two-arm superiority randomized controlled clinical trial.

Setting: The trial will be conducted at a work-related injuries specialised hospital, MAZ Hospital, Zaragoza, Spain.

Participants: Participants will be active workers who have suffered an acute ACL tear and they have undergone ACL reconstruction (n=60).

Intervention: Patients will recieve a 14-16-week supervised accelerated early rehabilitation protocol; one group will complete it applying blood flow restriction training and the other will not.

Main Outcome and Measure: The primary outcomes will be peak quadriceps strength and rate of torque development measured both isometrically and isokinetcally with a Isokinetic Dynamometer CON-TREX MG.

Limitations: Potential limitations include patients and physiotherapists are not blinded.

Conclusions: The focus of the research will examine the impact of blood flow restriction rehabilitation on patients who have undergone ACLR.

Relevance: The study has potential to restore quadriceps strength to a greater extent than standard rehabilitation protocol. Moreover, patients will spend less time in the rehabilitation process to return to work compared to standard care.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Male or female (18-65 years of age); must be skeletally mature with closed physes * Worker active * Diagnosis of acute (\<8 weeks), unilateral ACL tear with planned surgery confirmed via clinical examination and MRI * No previous ACL injury or reconstruction on the involved limb * Planned graft: autologous ipsilateral hamstring graft for ACL reconstruction * Planned fixation: suspensory cortical femoral device and tibial interference screw Exclusion Criteria: * Completed knee dislocation or multiligament injury (PCL, MCL, LCL) * ACL Graft diameter \< 8mm * Meniscal suture or meniscal root reattachment * Post-surgical immobilization * Any current or previous conditions or surgeries that might affect gait * Pregnant * Spinal fusion * Any implanted medical device or other contraindications for MRI * History of deep vein thrombosis and/or varicose veins or familiy history of deep vein thrombosis * Taking anti-coagulant drugs for any blood, cardiac or congenital disease that may cause coagulation disorders * Taking bone and muscle metabolism-modulation drugs or muscle supplements (e.g., creatine, amino acids, whey protein,…) * Recent inflammation, bleeding disorders, active bleeding, or infection within the lower limbs * Diabetic or have uncontrolled hypertension * Diminished capacity to provide informed consent * Unfeasible to attend regular physical therapy and study visits

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
MAZ Hospital Zaragoza Zaragoza

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07311031 on ClinicalTrials.gov ↗ ← All trials in Spain